Dr. Teresa Anne Petrilla is a pharmacist who is specialized in Pharmacotherapy in Fairfield, California. Patients can reach her at 1550 Gateway Blvd, Fairfield or contact her on 707-427-4425. Active license number of Dr. Teresa Anne Petrilla is RPH47044 for Pharmacotherapy in California. Dr. Teresa Anne Petrilla is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Teresa Anne Petrilla speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Teresa Anne Petrilla are as mentioned below.
NPI Number:
1962594523
NPI Enumeration Date:
29 Sep, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Teresa Anne Petrilla are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
RPH47044
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1550 Gateway Blvd, Fairfield, California
Zip:
94533-6901
Phone Number:
707-427-4425
Fax Number:
707-427-4384
Patients can reach Dr. Teresa Anne Petrilla at 1550 Gateway Blvd, Fairfield, California or can call on phone at 707-427-4425.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.